![John Tchelingerian](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Tchelingerian
Chairman at
Antion Biosciences SA
Profile
John Tchelingerian is the founder of Neurotech Pharmaceuticals, Inc. (United States),Keyobs SA. He currently holds the position of Chairman at Antion Biosciences SA, Chairman-Supervisory Board at Pan Cancer T, and Director at BioWin ASBL.
Previously, he served as President, Chief Executive Officer & Director at PROMETHERA Biosciences SA from 2015 to 2020.
He was also Chairman at Tc Land Expression SA in 2012 and held the position of Principal at Diatos SA. Additionally, he served as a Director at Endotis Pharma SARL. Dr. Tchelingerian holds a doctorate degree from Université Pierre et Marie Curie.
John Tchelingerian active positions
| Companies | Position | Start |
|---|---|---|
BioWin ASBL
 BioWin ASBL Miscellaneous Commercial ServicesCommercial Services Provides support for research and development of biomarkers | Director/Board Member | - |
Pan Cancer T
 Pan Cancer T BiotechnologyHealth Technology Develops T cell therapies | Chairman | - |
Antion Biosciences SA
 Antion Biosciences SA BiotechnologyHealth Technology Develops allogeneic therapies | Chairman | 2023-08-08 |
Former positions of John Tchelingerian
| Companies | Position | End |
|---|---|---|
PROMETHERA Biosciences SA
 PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cell therapy products to treat liver diseases | Chief Executive Officer | 2020-08-26 |
Diatos SA
 Diatos SA Pharmaceuticals: MajorHealth Technology Develops innovative therapies for the treatment of cancer | Corporate Officer/Principal | - |
Keyobs SA
 Keyobs SA Engineering & ConstructionIndustrial Services Provides geographical solutions for cartographic applications | Founder | - |
Neurotech Pharmaceuticals, Inc. (United States)
 Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Designs and develops therapeutic systems for retinal diseases | Founder | - |
Tc Land Expression SA
 Tc Land Expression SA Miscellaneous Commercial ServicesCommercial Services Develops gene expression biomarkers for transplantation and auto-immune disorders | Chief Executive Officer | - |
Training of John Tchelingerian
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
40
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Diatos SA
Diatos SA Pharmaceuticals: MajorHealth Technology Develops innovative therapies for the treatment of cancer | Health Technology |
Neurotech Pharmaceuticals, Inc. (United States)
Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Designs and develops therapeutic systems for retinal diseases | Health Technology |
Endotis Pharma SARL
 Endotis Pharma SARL Pharmaceuticals: MajorHealth Technology Develops cardiovascular therapeutics | Health Technology |
Université Pierre et Marie Curie
 Université Pierre et Marie Curie Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tc Land Expression SA
Tc Land Expression SA Miscellaneous Commercial ServicesCommercial Services Develops gene expression biomarkers for transplantation and auto-immune disorders | Commercial Services |
Keyobs SA
Keyobs SA Engineering & ConstructionIndustrial Services Provides geographical solutions for cartographic applications | Industrial Services |
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cell therapy products to treat liver diseases | Health Technology |
BioWin ASBL
BioWin ASBL Miscellaneous Commercial ServicesCommercial Services Provides support for research and development of biomarkers | Commercial Services |
Antion Biosciences SA
Antion Biosciences SA BiotechnologyHealth Technology Develops allogeneic therapies | Health Technology |
Pan Cancer T
Pan Cancer T BiotechnologyHealth Technology Develops T cell therapies | Health Technology |
- Stock Market
- Insiders
- John Tchelingerian
